Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
10/08/2009 | CA2720343A1 Heterocyclic derivative and use thereof |
10/08/2009 | CA2720112A1 Suture line administration technique using botulinum toxins |
10/08/2009 | CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof |
10/08/2009 | CA2720037A1 Purine derivatives as a3 adenosine receptor-selective agonists |
10/08/2009 | CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
10/08/2009 | CA2719985A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
10/08/2009 | CA2719502A1 Use of enteric glia |
10/08/2009 | CA2719070A1 Substituted piperidines as therapeutic compounds |
10/07/2009 | EP2107110A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
10/07/2009 | EP2107057A1 Process for the preparation of pure duloxetine hydrochloride |
10/07/2009 | EP2106802A1 Modified peptides as synthetic vaccines in amyloid-associated disease |
10/07/2009 | EP2106797A2 Controlled release oxycodone compositions |
10/07/2009 | EP2106796A2 Controlled release oxycodone compositions |
10/07/2009 | EP2032596B1 Neuroprotective compounds and uses thereof |
10/07/2009 | EP1917014B1 Neurorestoration with r(+) pramipexole |
10/07/2009 | EP1915375B1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics |
10/07/2009 | EP1756087B1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
10/07/2009 | EP1655032B1 USE OF THE P2X7 ANTAGONISTS o-ATP OR BBG FOR THE TREATMENT OF THE NEURODEGENERATIVE PHASE OF MULTIPLE SCLEROSIS |
10/07/2009 | EP1650182B1 Branched carboxylic acid compound and use thereof |
10/07/2009 | EP1617216B1 Novel method of screening |
10/07/2009 | EP1537113B1 Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
10/07/2009 | EP1509227B1 A buffered, liquid nicotine composition for pulmonary administration |
10/07/2009 | EP1385550B1 Therapeutic medicaments for inducing tolerance |
10/07/2009 | EP1317285B1 Methods for treating demyelinating diseases |
10/07/2009 | EP1311249B1 Set of transdermal therapeutic systems |
10/07/2009 | EP1308441B1 2-aminopyridine compounds and use thereof as drugs |
10/07/2009 | EP1180036B1 Cell therapy for chronic stroke |
10/07/2009 | EP1104301B1 Treatment of psychosis or neuropsychiatric symptoms associated with Alzheimer's Disease |
10/07/2009 | EP1000043B1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
10/07/2009 | CN101553567A Method for inhibiting or treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
10/07/2009 | CN101553486A Oxadiazole and thiadiazole compounds and their use as nicotinic acetylcholine receptor modulators |
10/07/2009 | CN101553484A Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
10/07/2009 | CN101553475A Hydroxamates as inhibitors of histone deacetylase |
10/07/2009 | CN101553467A 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands |
10/07/2009 | CN101553256A Phenylpropionamide compounds and the use thereof |
10/07/2009 | CN101553231A Modulators of muscarinic receptors |
10/07/2009 | CN101553216A Treatment of inflammatory diseases |
10/07/2009 | CN101550174A 2-amino-4-(4-beta-D-allopyranosid-phenyl)-6-phenyl-pyrimidine, preparation method and application thereof |
10/07/2009 | CN101550173A 4-(4-beta-D-allopyranosid-phenyl)-2-aryl-5-nitrilyl-6-methoxyl pyridine and preparation method and application thereof |
10/07/2009 | CN101550132A Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
10/07/2009 | CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity |
10/07/2009 | CN101550111A Preparation method of 2,5-bichlorphenyl-1,3,4-furodiazole |
10/07/2009 | CN101550103A 1, 2, 3, 4-tetrahydroisoquinoline derivatives and synthetic method and uses thereof |
10/07/2009 | CN101549147A Function of small RNA molecule aiming at c-Jun amino terminal kinase of human for senile dementia |
10/07/2009 | CN101549124A Pharmaceutical composition for nourishing heart, tranquillization, strengthening spleen and benefiting qi and preparation method thereof |
10/07/2009 | CN101549119A Pharmaceutical composition for treating idiopathic facial palsy |
10/07/2009 | CN101549114A Traditional Chinese medicine composition for treating insomnia and preparation method thereof |
10/07/2009 | CN101549108A Gastrodia tuber polygala capsules for improving memory and method for preparing same |
10/07/2009 | CN101549107A Gastrodia buccal tablet |
10/07/2009 | CN101549105A Traditional Chinese medicine composition for treating migraine |
10/07/2009 | CN101549104A Traditional Chinese medicine composition for treating trigeminal neuralgia and preparation method thereof |
10/07/2009 | CN101549094A Pharmaceutical composition for replenishing vital essence and blood, activating qi, resolving stagnation and tranquilization |
10/07/2009 | CN101549088A Traditional Chinese medicine for treating neurasthenia and preparation method thereof |
10/07/2009 | CN101549085A Traditional Chinese medicine for treating neurasthenia and preparation method thereof |
10/07/2009 | CN101549083A Chinese materia medica foot bath preserving health essence |
10/07/2009 | CN101549082A Traditional Chinese medicine composite used for treating parkinsonism syndrome and preparation method thereof |
10/07/2009 | CN101549080A Health medicated wine for treating insomnia |
10/07/2009 | CN101549078A Pharmaceutical composition for treating intractable insomnia and preparation method thereof |
10/07/2009 | CN101549063A Traditional Chinese medicine preparation for treating sleep disorder |
10/07/2009 | CN101549062A Pharmaceutical composition for relieving convulsion and calming the nerves and preparation method thereof |
10/07/2009 | CN101549054A Pharmaceutical composition for safely and effectively treating insomnia and preparation method thereof |
10/07/2009 | CN101549053A Medicine for treating Parkinson's disease and production method thereof |
10/07/2009 | CN101549046A Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
10/07/2009 | CN101549033A Headache treating medicine patch for external use and preparation method thereof |
10/07/2009 | CN101549017A Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof |
10/07/2009 | CN101549013A Capsule, tablet and granules of minium and preparation method |
10/07/2009 | CN101548998A Antidepressive medicine application of notoginseng leaf triterpenes |
10/07/2009 | CN101548995A Application of Viscum album extract as NF-kB inhibitor |
10/07/2009 | CN101548987A Cell culturing extract for degrading amyloid beta, preparation method and application thereof |
10/07/2009 | CN101548986A Cerebrospinal fluid extract for degrading amyloid beta, preparation method and application thereof |
10/07/2009 | CN101548981A Application of ginsenosides Rg1, Rh1 and Ppt to resistance of cognitive competence and study memory function disorders |
10/07/2009 | CN101548980A Application of geniposide, derivative and analog thereof in preparing anxiolytic medicine for preventing and/or treating depression |
10/07/2009 | CN101548969A Use of ethyl malonyl silybin derivant in preparing antioxidant medicine |
10/07/2009 | CN101548950A Tripterine nanometer lipid injection and method for preparing same |
10/07/2009 | CN100547003C Antibodies to human IL-1 beta |
10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
10/07/2009 | CN100546648C Transdermal botulinum toxin compositions |
10/07/2009 | CN100546599C Traditional Chinese medicine for curing neurasthenia |
10/07/2009 | CN100546592C Herbal formulation containing centella asiatica and sesamum indicum as brain tonic |
10/07/2009 | CN100546581C Combinations comprising anti-epileptic drugs for the treatment of neurological disorders. |
10/07/2009 | CN100546580C Nicotin or isonicotin benzothiazole derivatives |
10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
10/06/2009 | US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
10/06/2009 | US7598284 Indazole compounds as B3 adrenoceptor agonist |
10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
10/06/2009 | US7598271 Crystalline paroxetine methane sulfonate |
10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
10/06/2009 | US7598256 Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists |
10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
10/06/2009 | US7598244 (S)-1-(3-ethoxy-1-methylpropyl)-3-[7-(3,4-methylenedioxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]urea; preventive and/or therapeutic agent for immunological rejection and/or graft versus host reaction in organ/bone marrow transplant, autoimmune disease, allergic disease and/or inflammatory disease |
10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
10/06/2009 | US7598239 Side effect reduction; antiproliferative agents; schizophrenia |
10/06/2009 | US7598236 Diazabicyclic central nervous system active agents |
10/06/2009 | US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
10/06/2009 | US7598048 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
10/06/2009 | CA2485631C System and method for transparent early detection, warning, and intervention during a medical procedure |
10/06/2009 | CA2402431C 1,2,3,4-tetrahydroisoquinoline derivatives |
10/06/2009 | CA2381323C Amyloid .beta. protein (globular assembly and uses thereof) |